Psoriatic arthritis is a form of joint inflammation in people with psoriasis. However, not all people with psoriasis will develop psoriatic arthritis. Some psoriatic arthritis symptoms include painfully inflamed joints and changes in the eyes and the fingernails.

 

Infliximab is approved to reduce the signs and symptoms of psoriatic arthritis. The drug does more than just improve the symptoms; it actually helps to prevent joint damage and worsening of the disease.

 

Rheumatoid arthritis is an autoimmune disease. This means that, for some reason, the immune system mistakes a person's own cells as invaders and attacks them, causing damage. Scientists still do not know the causes of rheumatoid arthritis.

 

There are many symptoms of rheumatoid arthritis, including chronic pain and tender, warm, and swollen joints. Infliximab is approved to treat these symptoms, as well as to prevent future joint damage.

 

Infliximab is approved for use as a rheumatoid arthritis treatment only when it is combined with methotrexate (Rheumatrex^®), another rheumatoid arthritis medication.

 

Ulcerative colitis is a type of inflammatory bowel disease (IBD) that leads to inflammation and sores in the lining of the large intestine and rectum. It commonly causes abdominal pain (stomach pain), diarrhea, rectal bleeding, or an extreme urgency to have a bowel movement. At this time, the causes of ulcerative colitis are not fully understood. Although complications associated with the condition can be quite severe, there is one ulcerative colitis cure -- surgery (see Ulcerative Colitis Surgery). For those cases where surgery is not considered, treatment options include the following:

 

Infliximab is approved to treat ulcerative colitis, helping to reduce symptoms. In some people, the drug may even cause a remission of ulcerative colitis. It can also allow people to stop taking steroids for ulcerative colitis.